Prot # AI443131: Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects infected with Chronic Hepatitis C (FOURward Study)

  • Flamm, Steven L (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/30/14 → 7/30/17

Funding

  • Bristol-Myers Squibb Company (AI443131)